A study published recently in the Journal of Clinical Investigation and the National Institute of Health has found that the cannabis compound cannabidiol, often referred to simply as CBD, may provide a potential treatment for acne.
For the study, researchers used cannabidiol derived from cannabis on human sebaceous gland function, and determined that CBD behaves as a highly effective sebostatic agent.
“Administration of CBD to cultured human sebocytes and human skin organ culture inhibited the lipogenic actions of various compounds, including arachidonic acid and a combination of linoleic acid and testosterone, and suppressed sebocyte proliferation via the activation of transient receptor potential vanilloid-4 (TRPV4) ion channels”, claims researchers.
They continue; “Activation of TRPV4 interfered with the prolipogenic ERK1/2 MAPK pathway and resulted in the downregulation of nuclear receptor interacting protein-1 (NRIP1), which influences glucose and lipid metabolism, thereby inhibiting sebocyte lipogenesis. CBD also exerted complex antiinflammatory actions that were coupled to A2a adenosine receptor-dependent upregulation of tribbles homolog 3 (TRIB3) and inhibition of the NF-κB signaling.”
The study concludes; “Collectively, our findings suggest that, due to the combined lipostatic, antiproliferative, and antiinflammatory effects, CBD has potential as a promising therapeutic agent for the treatment of acne vulgaris.”
The research can be found on the National Library of Medicine’s website by clicking here.